HYDERABAD, India, May 20, 2013 (DNA : DAILY NEWS & ANALYSIS (INDIA)) - Consumers may celebrate the new drug price control order (DPCO), which was...
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients SANTA CLARA, Calif. --(...
Vortioxetine clinical phase III data show significant improvement in symptoms of major depression Takeda and Lundbeck present results from pivotal...
In what is apparently an unusual move, the US Department of Agriculture earlier this year fined Bristol-Myers Squibb for violating the Animal Welfare...
As the day winds down, take a moment to catch up on items you may have missed while sitting through that big meeting or maneuvering those career obstacles...
Health Canada Removes Novartis' Prexige From The Market (CanadianPress.com)
Medco Health CFO To Retire In March (Yahoo/Reuters)
Bioenvision Says 47 Percent Of Shareholders Back Genzyme Deal (Bloomberg News)
